Pharmafile Logo

Fix-a-Form International Ltd

Label printing specialists – Fix-a-Form International (UK) is backed by a global network of independent label printers offering specialist on-pack solutions via a comprehensive range of leaflet label products. Devised in the late 1970’s, the Fix-a-Form® multi-page product range has since helped many of the world’s brand owners and manufacturers to enhance their products and packaging. Operating via an exclusive network of label printing experts, Fix-a-Form International ensures local supply of the highest quality and standard in over 50 countries worldwide. Our licensee network are all specialist label printers serving a wide range of market sectors. Whether you require Pharmaceutical labelling, agrochemical labelling, promotional labels or consumer food/ informational labels, the Fix-a-Form network can provide outstanding custom labels to suit virtually any product container or package.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Kempson Way, Bury St Edmunds, Suffolk, IP32 7AR, United Kingdom
+44 (0)1284723144

 Latest Content from PMHub 

Pegasus Moves to Brighton

Press Releases | April 29, 2014 | Inizio

Top UK Healthcare Communications Consultancy Moves to Brighton

UX: Designing Human Experiences

Applying science to the creative process to improve lives

08 UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

07 Good Pharma

Better for patients, better for business

05 Social Media: A Health Hazard?

The case to embrace going social

Creating a Lifeline to the New Digital User

Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

Warehousing of HCV patients reaches new high

White Papers and Resources | December 19, 2013 | Inizio

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

White Papers and Resources | December 19, 2013 | Inizio

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.